 cholesteryl ester transfer plasma patients hypercholesterolemia mechanism underlie abnormal cholesteryl ester transfer CET patients hypercholesterolemia dysfunctional step reverse cholesterol transport subjects heterogeneous forms hypercholesterolemia HC HC patients mass CE whole plasma HDL VLDL LDL controls disturbance series recombination experiments HC acceptor VLDL LDL fraction controls donor HDL CE-transfer protein CETP converse combination characteristics accelerated CET intact HC plasma abnormal transfer HC acceptor lipoproteins HC VLDL subfractions LDL control fractions CET Consistent acceleration neutral lipid transfer reaction HDL HC vivo triglyceride/CE ratio HC HDL CETP mass HC plasma micrograms/ml control micrograms/ml mean SD series observations CET plasma HC patients disturbance results dysfunction subfraction elevation CETP levels abnormality type vivo accumulation atherogenic CE-enriched apoB-containing lipoproteins plasma additional unrecognized factor cardiovascular risk HC patients